Closed Protocol
Resources for Members
Clinical Trials
Files with the extension 'zip' require the Winzip application to open.
2011-413
CALGB 50901: A Phase II Trial of Ofatumumab (CALGB IND #112390) in Previously Untreated Follicular Non-Hodgkin's Lymphoma (NHL) more details
 Protocol
 Consent Form
|
|
| |
2012-010
SWOG S1108: A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237, in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin's Lymphoma more details
Protocol
Consent Form
|
|
| |
2010-082
GAO4753g: An open-label, multicenter, randomized, phase III study to investigate the efficacy and safety of bendamustine compared with bendamustine + RO5072759 (GA101) in patients with rituximab-refractory, indolent Non-Hodgkin's Lymphoma more details
Protocol
Consent Form
|
|
| |
2010-340
CALGB 50801: Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and II Classical Hodgkin Lymphoma (HL) more details
Protocol
Consent Form
|
|
| |
2010-394
An Open-Label, Multicenter Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia more details
Protocol
Consent Form
|
|
| |
2010-182
Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma more details
Protocol
Consent Form
|
|
| |
2012-1513
An Open-label, Multicenter, Single-arm, Phase 2 Study of PCI-32765 (Ibrutinib) in Subjects with Refractory Follicular Lymphoma more details
Protocol
Consent Form
|
|
| |
2013-0432
A05113: A phase I study of Rituximab, Lenolidomide, and Ibrutinib in Previously Untreated Follicular Lymphoma more details
Protocol
Consent Form
|
|
| |
Pro00000527
ECOG E1411: Intergroup Randomized Phase II Four Arm Study in Patients >/= 60 with Previously Untreated Mantle Cell Lymphoma more details
Protocol
Consent Form
|
|
| |
2012-1085
A Randomized, Open Label, MultiCenter, Phase II Trial Evaluating the Safety and Activity of DCDT2980S in Combination with Rituximab or DCDS4501A in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma more details
Protocol
Consent Form
|
|
| |
|
